These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34895425)

  • 1. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
    Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance of the Asia-Pacific Colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta-analysis and systematic review.
    Luu MN; Trinh NA; Tran TLT; Dang TP; Hiyama T; Quach DT
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1000-1007. PubMed ID: 38425009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
    Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
    Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of hypersensitive quantitative fecal immunochemical test and qualitative fecal occult blood test for colorectal cancer and advanced adenoma].
    Zhou RC; Wang PZ; Ma MJ; Meng FY; Li YY; Zhang Y; Yang XY; Li YQ; Zuo XL
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(46):3667-3672. PubMed ID: 36509537
    [No Abstract]   [Full Text] [Related]  

  • 7. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
    Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
    Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
    Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
    Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
    He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
    BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.
    Xu J; Rong L; Gu F; You P; Ding H; Zhai H; Wang B; Li Y; Ma X; Yin F; Yang L; He Y; Sheng J; Jin P
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1627-1636.e4. PubMed ID: 36113828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population.
    Kong Y; Zhuo L; Dong D; Zhuo L; Lou P; Cai T; Chen S; Pan J; Gao Y; Lu H; Ma Y; Dong Z; Luo X; Zhao H
    BMC Cancer; 2022 Sep; 22(1):961. PubMed ID: 36071414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.
    Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN
    J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The optimal thresholds of the quantitative fecal immunochemical test for opportunistic screening of colorectal neoplasia].
    Kang Q; Li N; Su H; Yang L; He YQ; Jia KM; Wang X; Jin P; Sheng JQ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):767-770. PubMed ID: 32192290
    [No Abstract]   [Full Text] [Related]  

  • 15. A modified colorectal screening score for prediction of advanced neoplasia: A prospective study of 5744 subjects.
    Sung JJY; Wong MCS; Lam TYT; Tsoi KKF; Chan VCW; Cheung W; Ching JYL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):187-194. PubMed ID: 28561279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.
    Tran CT; Nguyen MV; Tran MT; Tuong TT; Tran QH; Le LC; Pham HT; Bui NC; Vu HH; Nguyen TT; Ta PQ; Ha HT; Trinh DT; Bui HT; Trinh DQ; Van Nguyen K; Le SH; Van Vu K; Van Tran T; Tran HT; Shrubsole MJ; Ye F; Cai Q; Zheng W; Boffetta P; Shu XO; Luu HN
    Jpn J Clin Oncol; 2022 Jul; 52(7):707-715. PubMed ID: 35383373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool.
    Corte C; Zhang L; Chen J; Westbury S; Shaw J; Yeoh KG; Leong R
    J Gastroenterol Hepatol; 2016 Feb; 31(2):370-5. PubMed ID: 26485170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.
    Maeda Y; Gray E; Figueroa JD; Hall PS; Weller D; Dunlop MG; Din FVN
    BJS Open; 2021 Jul; 5(4):. PubMed ID: 34228096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.